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ABSTRACT
Loss of cardiac macroautophagy/autophagy impairs heart function, and evidence accumulates that an increased
autophagic ﬂux may protect against cardiovascular disease. We therefore tested the protective capacity of the
natural autophagy inducer spermidine in animal models of aging and hypertension, which both represent major
risk factors for the development of cardiovascular disease. Dietary spermidine elicits cardioprotective effects in
aged mice through enhancing cardiac autophagy and mitophagy. In salt-sensitive rats, spermidine
supplementation also delays the development of hypertensive heart disease, coinciding with reduced arterial
blood pressure. The high blood pressure-lowering effect likely results from improved global arginine
bioavailability and protection from hypertension-associated renal damage. The polyamine spermidine is
naturally present in human diets, though to a varying amount depending on food type and preparation. In
humans, high dietary spermidine intake correlates with reduced blood pressure and decreased risk of
cardiovascular disease and related death. Altogether, spermidine represents a cardio- and vascular-protective
autophagy inducer that can be readily integrated in common diets.
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As the aged population is increasing, cardiovascular disease has
reached an epidemic status and is currently the leading cause of
deathworldwide. Aging as well as the associated cardiovascular dis-
ease are driven by systemic metabolic deteriorations, pointing to
multiorgan syndromes rather than simple diseases limited to the
heart. However, current standard pharmacological therapies typi-
cally have single molecular targets with limited effects often
restricted to the heart and/or the vessels, thereby underestimating
the complexity of the disease. Eventually, the only remedy currently
available is to combine many drugs, causing a wide array of side
effects. Therefore, a potential successful preventive or therapeutic
approach may require interventions with intrinsic multi-target
effects. In this regard, caloric or dietary restriction has proven to
trigger cardiovascular-, health-, and life span-promoting effects
that are likely mediated by several, probably intersecting, mecha-
nisms. These include, but are not limited to, the induction of pro-
tective autophagy, reduction of oxidative stress, anti-inﬂammatory
effects, enhanced mitochondrial function as well as other systemic
metabolic adaptations. However, rigorous food regimens are difﬁ-
cult to enforce at the population level, urging the need for so-called
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caloric restriction mimetics (CRM). CRM are deﬁned as auto-
phagy-inducing agents that mimic the beneﬁcial metabolic effects
of caloric restriction. One such CRM is the natural polyamine sper-
midine that we have described previously as a potent autophagy-
inducing and life span-prolonging agent in simple model
organisms.
In our recent study, we addressed the question whether die-
tary supplementation of spermidine may lead to cardioprotection
and life span extension in rodent models and whether this could
be translated to humans. We examined the effects of spermidine
in 2 different experimental settings, namely aging and hyperten-
sion, using physiologically aged C57BL/6 wild-type mice and
hypertensive Dahl salt-sensitive rats, respectively. In old mice,
dietary spermidine prolongs life span and prevents age-induced
hypertrophy and stiffness of the heart by improving the
mechano-elastical and metabolic properties of cardiomyocytes.
These effects translate into improved cardiac diastolic function
(i.e., relaxation and ﬁlling properties of the heart). Although
such diastolic dysfunction may not always be associated with
manifest heart failure, it is one of the most important risk factors
for this disease in both aged mice and humans. We therefore
consider aged C57BL/6 wild-type mice as a suitable and highly
relevant model of age-associated diastolic dysfunction and
impending heart failure. Dietary spermidine elicits its beneﬁcial
effects on a multi-systemic level (Fig. 1), as it (i) induces cardiac
autophagy and mitophagy, (ii) lowers the subclinical plasma lev-
els of the pro-inﬂammatory cytokine TNF/TNF-a, (iii) increases
TTN (titin) phosphorylation, a known molecular event that pro-
motes the intrinsic elasticity of cardiomyocytes, and (iv) enhan-
ces cardiac mitochondrial volume and respiration together with
an improved mitochondria-relevant metabolite composition.
Importantly, dietary spermidine fails to exert its heart-pro-
tective effects in mice with autophagy-deﬁcient
cardiomyocytes, arguing for autophagy as a pivotal mechanism
underlying spermidine-induced cardioprotection. Autophagy
may act through the detoxiﬁcation of long-lived damaged pro-
teins or protein aggregates that otherwise compromise the
functionality of cardiomyocytes, and/or by degrading defective
mitochondria (mitophagy), thus ensuring the ‘metabolic ﬁt-
ness’ of cardiac cells. Autophagy may also be involved in yet
undeﬁned signaling processes that affect the molecular events
essential for cardiovascular health. Future research will eluci-
date, which of the described molecular events induced by sper-
midine (including phosphorylation of TTN and the reduction
of circulating levels of TNF) are autophagy-dependent. Alter-
natively, primarily autophagy-independent mechanisms may
also act in an additive or synergistic manner to autophagy.
In hypertensive rats, dietary spermidine delays the onset
of salt-induced hypertension, again preserving diastolic
function via reﬁnement of myocardial compliance (i.e., elas-
ticity). This effect protects animals from the progression to
heart failure, which is observed in control rats that are not
fed spermidine. The high blood pressure-lowering (anti-
hypertensive) effect of spermidine can be, at least partly,
explained by an increase of global arginine bioavailability.
Arginine is known as the sole source for biosynthesis of the
vasodilator nitric oxide. Our results suggest that dietary
spermidine administration manipulates the intersecting cel-
lular routes of arginine- and polyamine-metabolism. As a
result of this manipulation, arginine may be favored for
nitric oxide production instead of being used for polyamine
biosynthesis. However, several questions regarding the anti-
hypertensive effect of spermidine remain to be answered in
future studies. For instance, will the anti-hypertensive effect
of spermidine be reproducible in other modalities
(i.e., etiologies) of hypertension? Can spermidine reverse
Figure 1. Spermidine improves cardiovascular health similar to caloric restriction. Comparison of the molecular and cellular changes induced by dietary spermidine rele-
vant to cardiovascular health is depicted. Spermidine-induced effects are compared with similar effects known for caloric restriction. White arrows illustrate that a process
is known to be up- or downregulated in response to caloric restriction, while black arrows show the changes elicited by dietary spermidine. GABR, global arginine bio-
availability ratio; NO, nitric oxide; TTN, titin. Note: parts of this ﬁgure are modiﬁed versions of Wikimedia commons “A kreislauf01.svg” (J€org Rittmeister, commons.wikime-
dia.org/wiki/File:Akreislauf01.svg) and “Blood vessels-en.svg” (Kelvinsong, commons.wikimedia.org/wiki/File:Blood_vessels-en.svg) both licensed under the Creative
Commons Attribution-Share Alike 3.0 unported license (creativecommons.org/licenses/by-sa/3.0/).
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already developed hypertension? Finally, it should also be
addressed whether spermidine and other CRM share a com-
mon mechanism that underlies the blood pressure-lowering
effects, speciﬁcally addressing the role of autophagy in
blood pressure regulation.
In humans, spermidine-rich diet, as assessed by food
questionnaires, is associated with reduced blood pressure
and decreased risk of heart failure and cardiovascular dis-
ease. Hence, it will be crucial to test—in interventional pro-
spective clinical studies—for additive or synergistic effects
of dietary spermidine as an adjuvant in the current stan-
dard management strategies against cardiovascular disease.
For example, supplementation of spermidine or spermidine-
rich natural food extracts along with anti-hypertensive or
heart-supporting drugs in the setting of hypertension or
heart failure may help to reduce the number and/or the
dose of combined medications and, thus, alleviate their
potential adverse effects.
In summary, the multi-faceted beneﬁcial effects elicited by
dietary spermidine, phenocopy many of the known molecular,
metabolic, and physiological consequences of caloric restriction
(Fig. 1). Hence, the CRM spermidine can be a novel and feasi-
ble strategy in the combat against the dominant cause of death
worldwide: heart disease.
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